Large-scale testing (Phase 3)UnknownNCT01654146What this trial is testingICON8: Weekly Chemotherapy in Ovarian CancerWho this might be right forOvarian Cancer Medical Research Council 1,485
Testing effectiveness (Phase 2)Study completedNCT01583322What this trial is testingVargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian CancerWho this might be right forOvarian Cancer ARCAGY/ GINECO GROUP 188
Early research (Phase 1)Looking for participantsNCT05005403What this trial is testingStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab AdizutecanWho this might be right forNon-Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaMicro Satellite Stable Colorectal Cancer+4 more AbbVie
Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Testing effectiveness (Phase 2)Ended earlyNCT02874430What this trial is testingMetformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine CancerWho this might be right forBreast CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+2 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 29
Testing effectiveness (Phase 2)Study completedNCT02107937What this trial is testingPhase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian CarcinomaWho this might be right forOvarian NeoplasmsOvarian Epithelial Cancer SOTIO a.s. 136
Early research (Phase 1)Looking for participantsNCT05542407What this trial is testingONC201 and Atezolizumab in Obesity-Driven Endometrial CancerWho this might be right forEndometrial CancerMetastasisEndometrioid Endometrial Cancer+5 more UNC Lineberger Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT04739800What this trial is testingComparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic AgentsWho this might be right forFallopian Tube Mucinous AdenocarcinomaOvarian Seromucinous CarcinomaPlatinum-Refractory Fallopian Tube Carcinoma+47 more National Cancer Institute (NCI) 120
Not applicableLooking for participantsNCT02073500What this trial is testingPeritoneal Surface Malignancies - Characterization, Models and Treatment StrategiesWho this might be right forPseudomyxoma PeritoneiColorectal CarcinomaOvarian Carcinoma+1 more Oslo University Hospital 300
Not applicableActive Not RecruitingNCT07678008What this trial is testingPrognostic Value of KELIM Score and Inflammatory Markers in Ovarian CancerWho this might be right forAdvanced Ovarian Cancer (Stage III or IV) After Neoadjuvant ChemotherapyHigh-grade Serous Ovarian Carcinoma Aya Ahmed Nasser 80
Testing effectiveness (Phase 2)Study completedNCT00939809What this trial is testingA6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forFallopian Tube CarcinomaMalignant Ovarian Mixed Epithelial TumorOvarian Brenner Tumor+7 more Gynecologic Oncology Group 31
Very early researchActive Not RecruitingNCT05415709What this trial is testingHyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal CancerWho this might be right forFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Serous Adenocarcinoma+30 more Ohio State University Comprehensive Cancer Center 35
Not applicableStudy completedNCT04823871What this trial is testingEarly Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex SequencingWho this might be right forOvarian Epithelial CancerCarcinoma in SituOvarian Cancer Paul Speiser, Prof.MD, 406
Testing effectiveness (Phase 2)Study completedNCT01935934What this trial is testingCabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial CancerWho this might be right forEndometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Cell Adenocarcinoma+7 more National Cancer Institute (NCI) 102
Very early researchStudy completedNCT02111941What this trial is testingVaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerWho this might be right forFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid TumorFallopian Tube Mucinous Neoplasm+20 more Mayo Clinic 19
Testing effectiveness (Phase 2)Looking for participantsNCT04779554What this trial is testingFlat Dose vs. Weight-based IP Chemotherapy for CRS/HIPECWho this might be right forPeritoneal Carcinomatosis Prakash Pandalai 100
Early research (Phase 1)Study completedNCT00814086What this trial is testingCisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerWho this might be right forChemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more Gynecologic Oncology Group 23
Very early researchLooking for participantsNCT07341360What this trial is testingPseudovax - A Cancer Vaccine for Patients With Pseudomyxoma PeritoneiWho this might be right forPseudomyxoma Peritonei Oslo University Hospital 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02387203What this trial is testingAntibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal OriginWho this might be right forPseudomyxoma PeritoneiAppendiceal Neoplasms Mercy Medical Center 80
Large-scale testing (Phase 3)Looking for participantsNCT05256225What this trial is testingTesting the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or CarcinosarcomaWho this might be right forEndometrial CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated Carcinoma+5 more National Cancer Institute (NCI) 360